KLARSEN |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.24 EUR | +2.28% |
|
-20.00% | -17.65% |
| 15/03 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 2.500 | 3.380 | 2.900 |
| Spread/Res. | -10.40% | -33.73% | -22.76% |
| Spread/Supp. | +8.21% | +8.21% | +12.00% |
| Support | 2.070 | 2.070 | 2.000 |
- Stock Market
- Equities
- ALKLA Stock
- Charts Klarsen